You just read:

Neurocrine Biosciences Reports Positive Interim Results from Phase II Study of NBI-74788 in Adults with Classic Congenital Adrenal Hyperplasia

News provided by

Neurocrine Biosciences, Inc.

Mar 12, 2019, 08:00 ET